EP Patent

EP1858486A2 — Methods and compositions for minimizing accrual of inhalable insulin in the lungs

Assigned to Mannkind Corp · Expires 2007-11-28 · 18y expired

What this patent protects

lnhalable insulin compositions are provided that rapidly clear from the lungs of patients. Additionally, methods of minimizing insulin accrual after administration of an inhaled insulin composition are disclosed.

USPTO Abstract

lnhalable insulin compositions are provided that rapidly clear from the lungs of patients. Additionally, methods of minimizing insulin accrual after administration of an inhaled insulin composition are disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
EP1858486A2
Jurisdiction
EP
Classification
—
Expires
2007-11-28
Drug substance claim
No
Drug product claim
No
Assignee
Mannkind Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.